Helico is a biopharma company that intends to make plants able to manufacture lifesaving medicine.
Helico has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in May 2022.
Helico's investors include Icehouse Ventures, Outset Ventures, Custos Privatstiftung, David Ross.
Helico is headquartered in Auckland, New Zealand.
Helico is a biopharma company that intends to make plants able to manufacture lifesaving medicine.
Helico is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helico — Funding & Investors." VCBacked, May 17, 2022, https://www.vcbacked.co/company/helico. Accessed August 14, 2026.
VCBacked. (2022). Helico — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/helico
{{cite web |title=Helico — Funding & Investors |url=https://www.vcbacked.co/company/helico |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated